Active surveillance for non-muscle-invasive bladder cancer: fallacy or opportunity?
Purpose of review
This review aims to analyze the current place of active surveillance (AS) in non-muscle-invasive bladder cancer (NMIBC).
Recent findings
A growing body of evidence suggests that AS protocols for pTa low-grade (TaLG) NMIBC are safe and feasible. However, current guidelines have not implemented AS due to a lack of high-quality data. Available studies included pTa tumors, with only one study excluding pT1-NMIBC. Inclusion/exclusion criteria were heterogeneously defined based on tumor volume, number of tumors, carcinoma in situ (CIS), or high-grade (HG) NMIBC. Tumor volume
Source: Current Opinion in Urology - Category: Urology & Nephrology Tags: CONTROVERSIES AND NEW DEVELOPMENTS IN UROTHELIAL CARCINOMA: Edited by Shahrokh F. Shariat and Benjamin Pradere Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Carcinoma | Carcinoma in Situ | Study | Urology & Nephrology